The concentration of erlotinib in the cerebrospinal fluid of patients with brain metastasis from non-small-cell lung cancer
The concentration of erlotinib in the cerebrospinal fluid of patients with brain metastasis from non-small-cell lung cancer is a paper indexed in ScholarIQ from OpenAlex.
How many citations does The concentration of erlotinib in the cerebrospinal fluid of patients with brain metastasis from non-small-cell lung cancer have?
The concentration of erlotinib in the cerebrospinal fluid of patients with brain metastasis from non-small-cell lung cancer has 96 citations in the OpenAlex counts ScholarIQ stores.
When was The concentration of erlotinib in the cerebrospinal fluid of patients with brain metastasis from non-small-cell lung cancer published?
The concentration of erlotinib in the cerebrospinal fluid of patients with brain metastasis from non-small-cell lung cancer has 2013 year in the ScholarIQ index.
What is the open-access status of The concentration of erlotinib in the cerebrospinal fluid of patients with brain metastasis from non-small-cell lung cancer?
The concentration of erlotinib in the cerebrospinal fluid of patients with brain metastasis from non-small-cell lung cancer has bronze oa status in the ScholarIQ index.
What is the DOI of The concentration of erlotinib in the cerebrospinal fluid of patients with brain metastasis from non-small-cell lung cancer?
The DOI for The concentration of erlotinib in the cerebrospinal fluid of patients with brain metastasis from non-small-cell lung cancer is on the source record.
What is the PMID of The concentration of erlotinib in the cerebrospinal fluid of patients with brain metastasis from non-small-cell lung cancer?
The PMID for The concentration of erlotinib in the cerebrospinal fluid of patients with brain metastasis from non-small-cell lung cancer is on the source record.
What is the OpenAlex record for The concentration of erlotinib in the cerebrospinal fluid of patients with brain metastasis from non-small-cell lung cancer?
The OpenAlex for The concentration of erlotinib in the cerebrospinal fluid of patients with brain metastasis from non-small-cell lung cancer is on the source record.